ON24

ON24, Inc. provides webcasting and video communications solutions. It offers webinar-based marketing solutions that drive demand generation and customer engagement. The firm's products include ON24 Platform, ON24 Webcast Elite, ON24 Engagement Hub, ON24 Target, ON24 Intelligence, ON24 Connect, and ON24 Virtual Conference. The company was founded by Sharat Sharan and William Ryan Bales on January 8, 1998 and is headquartered in San Francisco, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

ON24 reports Q4 revenue growth, targets profitability by Q2 2023

ON24's Q4 performance showed revenue growth and a focus on core platform strength.
Challenges include headwinds in tech and manufacturing, pricing pressure, and lengthening sales cycles.
Opportunities lie in diversifying verticals, accelerating profitability, and driving customer adoption.
Overall, ON24 aims for profitability by Q2 2023 through strategic shifts and cost reductions.

ON24 reports resilient Q1 performance amidst market challenges and AI innovation

ON24's Q1 performance reflects resilience and strategic focus on profitability amidst market challenges and macroeconomic uncertainty.
The company's strengths in enterprise focus, innovation with AI, and cost discipline position it for future growth and shareholder value enhancement.
Challenges in customer budget pressures, pricing dynamics, and market uncertainties are being addressed as ON24 pursues opportunities in AI, market differentiation, and client expansion.

ON24 achieves breakeven in Q2, focuses on AI for growth

ON24's Q2 performance showed a focus on profitability and generative AI solutions. Challenges include revenue decline and customer impact from budget cuts. Opportunities lie in rebounding demand and leveraging data for growth.

ON24 reports strong Q3 results, eyes profitable growth in '24

ON24's Q3 performance showcased revenue growth, positive EPS, and improved retention rates.
The company's focus on AI innovation, cost reduction, and customer wins in regulated industries are key strengths.
Challenges include a sequential decrease in ARR and uncertainties in the enterprise installed base.
Opportunities lie in improved new business performance, growth in regulated industries, and long-term profitable growth targets.

ON24 reports robust Q4 performance, cautious 2024 outlook

ON24's Q4 2023 showcased strong financial performance, customer wins, and cost optimization efforts.
The company faces challenges in a volatile marketing budget environment but sees opportunities in AI solutions.
Maintaining fiscal discipline while investing in growth initiatives is key to achieving future targets.
AI-powered ACE presents a significant opportunity for revenue growth and enhanced customer engagement.

ON24 reports positive Q1 earnings, focuses on AI adoption and growth

ON24's Q1 performance showcased positive financial metrics and strategic initiatives, with a focus on AI technology adoption and profitability. Challenges include returning to growth amid sales cycle delays and customer churn. Opportunities exist in compliance-oriented AI work and enhancing customer engagement.

ON24 reports strong Q2 earnings, focuses on AI innovation

ON24 delivered a strong Q2 performance, surpassing revenue and non-GAAP EBIT expectations, achieving positive adjusted EBITDA and EPS for the fifth consecutive quarter. The company's focus on innovation, customer retention, and profitability is driving its success.
While facing challenges such as macroeconomic uncertainties and balancing cost management with R&D investment, ON24's strengths in financial performance, product innovation, and strategic priorities position it well for future growth.
Opportunities lie in leveraging the AI-powered ACE solution, expanding through enterprise go-to-market strategies, and exploring growth avenues with positive free cash flow and stabilized ending ARR.

ON24 exceeds Q3 expectations, focuses on growth and profitability

ON24's Q3 2024 earnings call highlighted strong financial performance, strategic focus on innovation and profitability, and positive outlook for revenue growth. Despite challenges in core platform ARR and profitability targets for 2025, the company's strengths in customer relationships, margin performance, and guidance raise optimism. Leveraging opportunities in AI solutions, customer win-backs, and market enhancements will be key for ON24's future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ON24, Inc. operates as cloud-based platform, which engages in digital engagement that delivers insights for revenue growth through interactive webinar experiences, virtual event experiences, and multimedia content experiences. It operates through the Subscription and Other Platform and Professional Services segments. The company was founded by Sharat Sharan and William Ryan Bales on January 8, 1998 and is headquartered in San Francisco, CA.

Angion Biomedica

Atotech

Bolt Biotherapeutics

Immunocore Holdings

Landos Biopharma

Lucira Health

Pharvaris B.V.

Sana Biotechnology

Sensei Biotherapeutics

Terns Pharmaceuticals

TELUS International (Cda)

Vor Biopharma

The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. German chemicals group Atotech downsized and priced below the range to raise $498 million at a $3.3 billion market cap.

U.S. IPO Weekly Recap: Biotechs Flood The IPO Market In A 14 IPO Week

ON24 is a B2B platform, which has gone public after seeing strong operational momentum in 2020. The company has seen strong growth in 2020, thanks to the pandemic, providing a boost to growth and margins.

ON24: Appeal And Concerns Around This Offering

NEW YORK, Feb. 3, 2021 /PRNewswire/ -- DLA Piper represented ON24 Inc. (NYSE: ONTF) in its initial public offering of 8,560,930 shares of common stock at a price to the public of $50 per share. ON24 is offering 6,315,789 shares of common stock, and certain selling stockholders are...

DLA Piper advises ON24 in its US$428 million IPO

The webinar specialist joins a hot market for IPOs.

Zoom Competitor ON24 to IPO

The software IPO craze continued Wednesday with shares of video-marketing company ON24 surging on their first day of trading.

IPO Report: ON24 stock jumps 54% after IPO

News for ON24 Stock (ONTF)